Treatment of alcoholic liver disease.

[1]  M. Gent,et al.  Colchicine in the treatment of cirrhosis of the liver. , 1988, The New England journal of medicine.

[2]  R. Moreau,et al.  Liver hypermetabolism during alcohol withdrawal in humans. Role of sympathetic overactivity. , 1988, Gastroenterology.

[3]  C. Naranjo,et al.  Serotonin Uptake Inhibitors Attenuate Ethanol Intake in Humans , 1988 .

[4]  Y. Israel,et al.  Long-term treatment of alcoholic liver disease with propylthiouracil. , 1987, The New England journal of medicine.

[5]  P. Calès,et al.  Propranolol in the prevention of first upper gastrointestinal tract hemorrhage in patients with cirrhosis of the liver and esophageal varices. , 1987, The New England journal of medicine.

[6]  Achord Jl.  A prospective randomized clinical trial of peripheral amino acid-glucose supplementation in acute alcoholic hepatitis. , 1987 .

[7]  C. Naranjo,et al.  The serotonin uptake inhibitor citalopram attenuates ethanol intake , 1987, Clinical pharmacology and therapeutics.

[8]  P. Ferenci,et al.  Silymarin Treatment in Patients with Cirrhosis of the Liver — a Prospective Study , 1987 .

[9]  C. Bode,et al.  Alcohol-induced liver injury after jejunoileal bypass operation in rats. , 1987, Journal of hepatology.

[10]  J. Henriksen,et al.  Liver haemodynamics and function in alcoholic cirrhosis. Relation to testosterone treatment and ethanol consumption. , 1987, Journal of hepatology.

[11]  J. Féher,et al.  A prospective multicenter study of insulin and glucagon infusion therapy in acute alcoholic hepatitis. , 1987, Journal of hepatology.

[12]  M. Morgan,et al.  Lactitol versus lactulose in the treatment of chronic hepatic encephalopathy. A double-blind, randomised, cross-over study. , 1987, Journal of hepatology.

[13]  J. Villeneuve,et al.  Propranolol for the prevention of recurrent variceal hemorrhage: A controlled trial , 1986, Hepatology.

[14]  F. Iber,et al.  Disulfiram Treatment of Alcoholism: A Veterans Administration Cooperative Study , 1986 .

[15]  C. Gluud.  Testosterone treatment of men with alcoholic cirrhosis: A double‐blind study , 1986, Hepatology.

[16]  T. Poynard,et al.  A randomized clinical trial of supplementary parenteral nutrition in jaundiced alcoholic cirrhotic patients , 1986, Hepatology.

[17]  J. Neuberger,et al.  Ethanol metabolism in the generation of new antigenic determinants on liver cells. , 1986, Gut.

[18]  G. D’Amico,et al.  A randomized clinical trial of propranolol for the prevention of initial bleeding in cirrhosis with portal hypertension. , 1986, The New England journal of medicine.

[19]  D. Dumitrascu,et al.  Colchicine treatment effects on liver cirrhosis assessed by liver blood flow measurements. , 1986, Medecine interne.

[20]  T. Tosch,et al.  VA Cooperative Study on Alcoholic Hepatitis. III: Changes in protein-calorie malnutrition associated with 30 days of hospitalization with and without enteral nutritional therapy. , 1985, JPEN. Journal of parenteral and enteral nutrition.

[21]  J. Boitnott,et al.  Effect of parenteral amino acid supplementation in alcoholic hepatitis , 1985, Hepatology.

[22]  P. Calès,et al.  Acute effect of propranolol on splanchnic circulation in normal and portal hypertensive rats. , 1985, Journal of hepatology.

[23]  L. Seeff,et al.  Short-term and long-term survival in patients with alcoholic hepatitis treated with oxandrolone and prednisolone. , 1984, The New England journal of medicine.

[24]  P. S. Sun,et al.  Centrilobular Liver Necrosis Induced by Hypoxia in Chronic Ethanol‐Fed Rats , 1984, Hepatology.

[25]  R. Poupon,et al.  A Randomized Controlled Study of Propranolol for Prevention of Recurrent Gastrointestinal Bleeding in Patients with Cirrhosis: A Final Report , 1984, Hepatology.

[26]  J. Lemasters,et al.  Is hypoxia involved in the mechanism of alcohol-induced liver injury? , 1984, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[27]  J. Neuberger,et al.  Antibodies to alcohol altered liver cell determinants in patients with alcoholic liver disease. , 1984, Gut.

[28]  R. Russell,et al.  Comparison of three adrenoreceptor blocking agents in patients with cirrhosis and portal hypertension. , 1984, Gut.

[29]  J. Kelemen,et al.  Clinical, enzymological and histological changes in chronic diffuse liver diseases following (+)-cyanidanol-3 (Catergen) treatment. , 1984, Acta physiologica Hungarica.

[30]  F. Salamon,et al.  Effects of (+)-cyanidanol-3 on chronic liver injury. , 1984, Acta physiologica Hungarica.

[31]  M. World,et al.  (+)-Cyanidanol-3 for alcoholic liver disease: results of a six-month clinical trial. , 1984, Alcohol and alcoholism.

[32]  F. Szalay,et al.  Therapeutic effect of (+)-cyanidanol-3 in toxic alcoholic liver disease and in chronic active hepatitis. , 1984, Acta physiologica Hungarica.

[33]  Y. Israel,et al.  Assessment of Prognostic Factors in Alcoholic Liver Disease: Toward a Global Quantitative Expression of Severity , 2007, Hepatology.

[34]  Y. Hasumura,et al.  The Role of Fat‐Storing Cells in Disse Space Fibrogenesis in Alcoholic Liver Disease , 2007, Hepatology.

[35]  A. Burroughs,et al.  Controlled trial of propranolol for the prevention of recurrent variceal hemorrhage in patients with cirrhosis. , 1983, The New England journal of medicine.

[36]  J. Benhamou,et al.  The Effect of Propranolol on Portal Hypertension in Patients with Cirrhosis: A Hemodynamic Study , 2007, Hepatology.

[37]  S. Sherlock,et al.  Treatment of alcohol-related liver disease with thioctic acid: a six month randomised double-blind trial. , 1982, Gut.

[38]  C. Lieber,et al.  Perivenular fibrosis in alcoholic liver injury: ultrastructure and histologic progression. , 1982, Gastroenterology.

[39]  S. Sarna,et al.  Effect of silymarin on chemical, functional, and morphological alterations of the liver. A double-blind controlled study. , 1982, Scandinavian journal of gastroenterology.

[40]  G. Kanel,et al.  Double-blind, controlled trial of propylthiouracil in patients with severe acute alcoholic hepatitis. , 1982, Gastroenterology.

[41]  R. N. Macsween,et al.  Liver membrane antibodies in alcoholic liver disease: 1. prevalence and immunoglobulin class. , 1982, Gut.

[42]  K. Raheja,et al.  Protective effect of propylthiouracil independent of its hypothyroid effect on acetaminophen toxicity in the rat. , 1982, The Journal of pharmacology and experimental therapeutics.

[43]  A. Eddleston,et al.  Controlled trial of methylprednisolone therapy in severe acute alcoholic hepatitis. , 1982, Gut.

[44]  T. Poynard,et al.  Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a controlled study. , 1981, The New England journal of medicine.

[45]  J. Saunders,et al.  Do women develop alcoholic liver disease more readily than men? , 1981, British medical journal.

[46]  J. Saunders,et al.  A 20-year prospective study of cirrhosis. , 1981, British medical journal.

[47]  J. Galambos,et al.  AMINOACID THERAPY OF ALCOHOLIC HEPATITIS , 1980, The Lancet.

[48]  M. Ehrenfeld,et al.  Effect of colchicine on polymorphonuclear leucocyte chemotaxis in human volunteers. , 1980, British journal of clinical pharmacology.

[49]  J. Saunders,et al.  Early diagnosis of alcoholic cirrhosis by the aminopyrine breath test , 1980 .

[50]  M. Omata,et al.  Double-blind controlled trial of prednisolone therapy in patients with severe acute alcoholic hepatitis and spontaneous encephalopathy , 1980 .

[51]  H. Iturriaga,et al.  Hepatic vein oxygenation, liver blood flow, and the rate of ethanol metabolism in recently abstinent alcoholic patients , 1971, European journal of clinical investigation.

[52]  D. Kershenobich,et al.  Treatment of cirrhosis with colchicine. A double-blind randomized trial. , 1979, Gastroenterology.

[53]  R. Fuller,et al.  Disulfiram for the treatment of alcoholism. An evaluation in 128 men. , 1979, Annals of internal medicine.

[54]  Y. Israel,et al.  Effect of short-term therapy with propylthiouracil in patients with alcoholic liver disease. , 1979, Gastroenterology.

[55]  L. Powell,et al.  Drug metabolism in liver disease. Identification of patients with impaired hepatic drug metabolism. , 1978, Gastroenterology.

[56]  P. Neuvonen,et al.  Effect of cirrhosis of the liver on the pharmacokinetics of chlormethiazole. , 1978, British medical journal.

[57]  Willis C. Maddrey,et al.  Corticosteroid therapy of alcoholic hepatitis. , 1978, Gastroenterology.

[58]  C. Lieber.  Pathogenesis and early diagnosis of alcoholic liver injury. , 1978, The New England journal of medicine.

[59]  F. Iber,et al.  A controlled trial of 6-methylprednisolone in acute alcoholic hepatitis. With a note on published results in encephalopathic patients. , 1978, The American journal of gastroenterology.

[60]  H. Fallon,et al.  Treatment of alcoholic hepatitis with encephalopathy. Comparison of prednisolone with caloric supplements. , 1978, Gastroenterology.

[61]  C. Lieber,et al.  Pathogenesis of alcohol-induced accumulation of protein in the liver. , 1977, The Journal of clinical investigation.

[62]  B. Portmann,et al.  Lymphocyte cytotoxicity for isolated hepatocytes in alcoholic liver disease. , 1977, Gastroenterology.

[63]  L. Seeff,et al.  Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial. , 1977, Gastroenterology.

[64]  J. Eccles.  Book ReviewElectric Current Flow in Excitable Cells. , 1976 .

[65]  C. M. Leevy,et al.  Alcoholic hepatitis. Cell-mediated immunological response to alcoholic hyalin. , 1976, Gastroenterology.

[66]  P. Schlichting,et al.  Alcoholic hepatitis superimposed on cirrhosis. Clinical significance and effect of long-term prednisone treatment. , 1976, Scandinavian journal of gastroenterology.

[67]  N. Bucher,et al.  Regulation of hepatic regeneration in rats by synergistic action of insulin and glucagon. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[68]  Y. Israel,et al.  Experimental alcohol-induced hepatic necrosis: suppression by propylthiouracil. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[69]  D. Kershenobich,et al.  Effect of colchicine on collagen, albumin and transferrin synthesis by cirrhotic rat liver slices. , 1975, Biochimica et biophysica acta.

[70]  U. Klotz,et al.  The effect of cirrhosis on the disposition and elimination of meperidine in man , 1974 .

[71]  R. Ross,et al.  EFFECTS OF ANTIMICROTUBULAR AGENTS ON THE SECRETION OF COLLAGEN , 1974, The Journal of cell biology.

[72]  F. Iber,et al.  Preliminary observations of d-penicillamine therapy in acute alcoholic liver disease. , 1974, Digestion.

[73]  T. Reynolds,et al.  Prednisone therapy of acute alcoholic hepatitis. Report of a controlled trial. , 1973 .

[74]  M J Mattila,et al.  Proceedings: Drug interaction on driving skills as evaluated by laboratory tests and by a driving simulator. , 1973, Pharmakopsychiatrie, Neuro-Psychopharmakologie.

[75]  D. Kershenobich,et al.  Colchicine and the treatment of liver cirrhosis. , 1973, Lancet.

[76]  C. Lieber,et al.  Hepatic Collagen Metabolism: Effect of Alcohol Consumption in Rats and Baboons , 1972, Science.

[77]  R. Veech,et al.  The time-course of the effects of ethanol on the redox and phosphorylation states of rat liver. , 1972, The Biochemical journal.

[78]  A. Gajdos,et al.  The effect of (+)-catechin on the hepatic level of ATP and the lipid content of liver during experimental steatosis. , 1972, Biochemical pharmacology.

[79]  C. Lieber,et al.  Increase of ethanol, meprobamate and pentobarbital metabolism after chronic ethanol administration in man and in rats. , 1971, The American journal of medicine.

[80]  G Scollo-Lavizzari,et al.  Treatment of chronic portal-systemic encephalopathy with lactulose. Report of six patients and review of the literature. , 1971, The American journal of medicine.

[81]  C. Pope,et al.  Corticosteroid therapy in severe alcoholic hepatitis. A double-blind drug trial. , 1971, The New England journal of medicine.

[82]  H. Fallon,et al.  Alcoholic hepatitis. Natural history and evaluation of prednisolone therapy. , 1971, Annals of internal medicine.

[83]  C. Lieber,et al.  Inhibition of drug metabolism by acute ethanol intoxication. A hepatic microsomal mechanism. , 1970, The American journal of medicine.

[84]  W. J. Powell,et al.  Duration of survival in patients with Laennec's cirrhosis. Influence of alcohol withdrawal, and possible effects of recent changes in general management of the disease. , 1968, The American journal of medicine.

[85]  D. Nr,et al.  Role of lipid peroxidation in the pathogenesis of the ethanol-induced fatty liver. , 1967, Federation proceedings.

[86]  L. Fenster.  The Nonefficacy of Short-term Anabolic Steroid Therapy in Alcoholic Liver Disease , 1966 .

[87]  L. H. Greenberg,et al.  Audiotoxicity and nephrotoxicity due to orally administered neomycin. , 1965, JAMA.

[88]  C. Fink.  Gonococcal arthritis in children. , 1965, JAMA.

[89]  S. Bengmark,et al.  THE EFFECT OF TESTOSTERONE ON LIVER HEALING AFTER PARTIAL HEPATECTOMY. , 1964, Acta chirurgica Scandinavica.

[90]  M. Girard.  [THE TREATMENT OF ALCOHOLIC CIRRHOSIS]. , 1963, Journal de medecine de Lyon.

[91]  J. Laidlaw,et al.  Morphine tolerance in hepatic cirrhosis. , 1961, Gastroenterology.

[92]  R. Wells.  Prednisolone and testosterone propionate in cirrhosis of the liver. A controlled trial. , 1960, Lancet.

[93]  M. Girolami.  TREATMENT OF ASCITIC ATROPHIC CIRRHOSIS OF THE LIVER WITH HIGH DOSAGES OF TESTOSTERONE PROPIONATE , 1958, Journal of the American Geriatrics Society.

[94]  R. E. Ranney,et al.  The ability of 17-ethyl-19-nortestosterone to block ethionine-induced fatty liver in rats. , 1957, Endocrinology.